BioVaxys Technology Corp.
BIOV
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 859.90K | 777.20K | 1.09M | 585.80K | 358.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 859.90K | 800.40K | 1.09M | 585.80K | 358.30K |
| Operating Income | -859.90K | -800.40K | -1.09M | -585.80K | -358.30K |
| Income Before Tax | -926.40K | -753.10K | -2.01M | -866.50K | -399.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -926.40K | -753.10K | -2.01M | -866.50K | -399.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -926.40K | -753.10K | -2.01M | -866.50K | -399.70K |
| EBIT | -859.90K | -800.40K | -1.09M | -585.80K | -358.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.03 | -0.03 | -0.08 | -0.04 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.08 | -0.04 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 28.82M | 26.22M | 24.26M | 22.01M | 20.82M |
| Average Diluted Shares Outstanding | 28.82M | 26.22M | 24.26M | 22.01M | 20.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |